[1]
“Exploring prognostic factors for HER2-positive metastatic breast cancer: a retrospective cohort study in a major Swiss hospital”, Swiss Med Wkly, vol. 146, no. 5152, p. w14393, Dec. 2016, doi: 10.4414/smw.2016.14393.